Pfizer is proud to launch the 2014 ASPIRE Rheumatology and Dermatology Research Awards

As competition for research funding increases, the ASPIRE program underscores Pfizer's commitment to supporting research in autoimmune diseases within rheumatology and dermatology.

Mission

The mission of the 2014 ASPIRE program is to support basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the epidemiology, pathogenesis and treatment of selected diseases.

The ASPIRE Program demonstrates Pfizer’s commitment to supporting promising investigators with an interest in advancing knowledge in defined disease areas within rheumatology and dermatology.

Background

Scientific research continues to advance our knowledge and understanding of autoimmune diseases within rheumatology and dermatology. The 2014 ASPIRE Rheumatology and Dermatology Research Awards are designed to fund research proposals aimed to further the understanding of certain autoimmune diseases within rheumatology (rheumatoid arthritis) and dermatology (plaque psoriasis) and contribute to excellence in patient care.

Areas of Focus

Research areas of interest in rheumatoid arthritis and plaque psoriasis are as follows:

Available Awards

Pfizer is funding up to 5 research awards up to a maximum of $150,000 each. Research projects are expected to complete within 2 years of study start.